Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Guizhou Xinbang Pharmaceutical Co Ltd
Other Liabilities
Guizhou Xinbang Pharmaceutical Co Ltd
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
|
Other Liabilities
¥22.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-8%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Other Liabilities
¥399.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
26%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Liabilities
¥22m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Other Liabilities
¥104.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Liabilities
¥39m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Liabilities
¥891.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
See Also
What is Guizhou Xinbang Pharmaceutical Co Ltd's Other Liabilities?
Other Liabilities
22.3m
CNY
Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Other Liabilities amounts to 22.3m CNY.
What is Guizhou Xinbang Pharmaceutical Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
-8%
Over the last year, the Other Liabilities growth was 16%. The average annual Other Liabilities growth rates for Guizhou Xinbang Pharmaceutical Co Ltd have been 2% over the past three years , -3% over the past five years , and -8% over the past ten years .